CRA Oversight in Modern Clinical Trials
As clinical trials become more complex and distributed, the role of CRA oversight is evolving. In this session, Sergio Rodríguez de Rivera Garrido, Associate Director, Clinical Operations at KCR, an ICON Plc company, will explore what effective oversight looks like today, how CRAs can add real value beyond checklists, and where judgment, risk awareness, and collaboration matter most in modern monitoring.
Learn more >
